Patented neonatal resuscitation device
UMP-123
A patented device that establishes access to the umbilical vein in the first minute after birth — so any clinician attending the delivery, not only specialists, can begin advanced resuscitation when a newborn needs it most.
The Device
The challenge
A critically ill newborn may need fluids and medication within minutes. Threading a catheter into the umbilical vein is delicate work — the vessel is soft, slippery and follows a spiralling path — so it has long been a task for the most experienced hands.
How it works
The UMP — an umbilical-vessel port — is a fine cannula with a smooth, rounded tip and curved anchors. It seats into the open vein, holds itself in place, and presents a standard connector for catheters and syringes. No forceps, no threading.
For the room
Because it removes the technical difficulty, the doctors, midwives and nurses already attending the birth can establish access in under a minute — without specialist training, wherever a child is born.
Patent
The UMP-123 is protected by patents granted in Norway, the United States, Europe, Japan and beyond.
- Invention
- Device for introducing and maintaining a port in an umbilical vessel
- Inventor
- Terje Eide
- Priority
- 25 March 2015 · NO 2015 0362
- Granted
- NO 338751 B1 · US 10,485,581 B2 · EP 3273860 B1
also Japan, China, Australia and Canada
Founder
Dr. Terje Eide
Terje is the founder of NeoResQ and the inventor of the UMP-123. He has practised anaesthesiology and intensive care for more than 30 years at hospitals across several countries, and holds the patent on the device's design.
Contact
For inquiries, write to
hello@neoresq.com